Therapeutic Advances In Rare Disease Indexing, Publication Fee / Time (2024)


therapeutic

Aim and Scope

The Therapeutic Advances In Rare Disease is a research journal that publishes research in the field of rare diseases, genetics, clinical medicine, clinical and molecular aspects of rare diseases, medicine. This journal is published by the SAGE Publishing. The ISSN of this journal is .

Also, please check the following important details about therapeutic advances in rare disease: Publisher, ISSN, Ranking, Indexing, Impact Factor (if applicable), Publication fee (APC), Review Time, and Acceptance Rate.

According to Clarivate's JCR, journals indexed in SCIE/SSCI have an impact factor.

The ISSN (International Standard Serial Number) is an 8-digit code used to uniquely identify journals. ISSN numbers are assigned by a network of ISSN National Centres, usually located at national libraries and coordinated by the ISSN International Centre based in Paris. The International Centre is an intergovernmental organization created in 1974 through an agreement between UNESCO and the French government.

Important Metrics

Journal Title: Therapeutic Advances in Rare Disease
Publisher: SAGE Publishing
P-ISSN:
E-ISSN: 2633-0040
Language: English
Country of Publisher: United Kingdom
APC: No
Processing Time (Weeks): 15
Review Process: Anonymous peer review
Subjects: Medicine: Internal medicine

Indexing

The therapeutic advances in rare disease is indexed in:

An indexed journal means that the journal has gone through and passed a review process of certain requirements done by a journal indexer.

The Web of Science Core Collection includes the Science Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI), Arts & Humanities Citation Index (AHCI), and Emerging Sources Citation Index (ESCI).


Publication fee

Based on the Official Journal Homepage, the therapeutic advances in rare disease does not charge any publication fee.

An article processing charge (APC), also known as a publication fee, is a fee which is sometimes charged to authors. Most commonly, it is involved in making a work available as open access (OA), in either a full OA journal or in a hybrid journal.


Journal Publication Time

The Journal Publication Time means the average number of weeks between article submission and publication. According to the journal website, the therapeutic advances in rare disease publishes research articles in 15 weeks on an average.



Call for Papers

Visit to the official website of the journal/ conference to check the details about call for papers.

How to publish in Therapeutic Advances In Rare Disease?

If your research is related to rare diseases, genetics, clinical medicine, clinical and molecular aspects of rare diseases, medicine, then visit the official website of therapeutic advances in rare disease and send your manuscript.

Tips for publishing in Therapeutic Advances In Rare Disease:

Acceptance Rate

Acceptance rate is the ratio of the number of articles submitted to the number of articles published. Researchers can check the acceptance rate on the journal website. Alternatively, they can contact the editor of the journal.

Final Summary

  • It is published by SAGE Publishing.
  • The journal is indexed in , DOAJ.
  • It is an open access journal.
  • The publication time (Average number of weeks between article submission and publication) of the journal is 15 weeks.
  • Based on the Official Journal Homepage, the therapeutic advances in rare disease does not charge any publication fee.

Sources: https://journals.sagepub.com/home/trd







SIMILIAR JOURNALS


GENE THERAPY

ISSN: 0969-7128
Publisher: SPRINGERNATURE

NON-CODING RNA

ISSN:
Publisher: MDPI

BIOCHEMICAL GENETICS

ISSN: 0006-2928
Publisher: SPRINGER/PLENUM PUBLISHERS

CHROMOSOMA

ISSN: 0009-5915
Publisher: SPRINGER

CHROMOSOME RESEARCH

ISSN: 0967-3849
Publisher: SPRINGER

COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY D-GENOMICS & PROTEOMICS

ISSN: 1744-117X
Publisher: ELSEVIER SCIENCE INC

CURRENT GENOMICS

ISSN: 1389-2029
Publisher: BENTHAM SCIENCE PUBL LTD

DNA AND CELL BIOLOGY

ISSN: 1044-5498
Publisher: MARY ANN LIEBERT, INC

EPIGENETICS

ISSN: 1559-2294
Publisher: TAYLOR & FRANCIS INC

EUROPEAN JOURNAL OF HUMAN GENETICS

ISSN: 1018-4813
Publisher: SPRINGERNATURE

TOP RESEARCH JOURNALS

Credit and Source: Scopus, Clarivate, UGC CARE.